Illinois Injury and Mass Tort Lawyer Blog

Published on: December 19, 2023

FDA Issues Warning of Rare but Serious Drug Reaction to the Antiseizure Medicines

pills-6605907_640-e1702315800250 The United States Food and Drug Administration (FDA) recently warned consumers that certain antiseizure medications can cause a rare but serious response called Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). When not diagnosed and treated rapidly, these can prove fatal. The affected seizure medications are levetiracetam (Keppra, Keppra XR, Elepsia XR, Spritam) and clobazam (Onfi, Sympazan). Patients are advised to seek medical attention if they develop swollen lymph nodes, fever, or unexplained rash. If you develop an adverse drug reaction to anti-seizure medications, you should call the seasoned Chicago-based dangerous drug lawyers of Moll Law Group. Billions have been recovered in product liability cases with which we’ve been involved.

Contact Moll Law Group About DRESS

The antiseizure medications are approved for different uses. Levetiracetam, which has been FDA-approved for 24 hours and can be accessed in several formulations under the brand names Keppra, Keppra XR, Elepsia XR, and Spritam, and as generics. It can be used along to treat seizures or with other medicines and can be accessed in many formulations under brand names.

Clobazam, for instance, is a benzodiazepine that is FDA-approved for use with other medicines to control linked to a type of epilepsy called Lennox-Gastaut Syndrome. Benzodiazepines depress the central nervous system, but DRESS and other skin reactions are associated with Clobazam, which has been approved by the FDA for 12 years, and not the other benzodiazepines. It can be accessed under the brand names Onfi and Sympazan, and as generics.

Continue reading →

Published on: December 15, 2023

The Centers for Disease Control and Prevention Announce a Listeria Outbreak

By Moll Law Group

fruit-7422698_640 The Centers for Disease Control and Prevention recently announced that a listeria outbreak arising out of stone fruit—nectarines, peaches, and plums—made people in seven states sick. Up to 11 people reported they became sick due to the outbreak. Ten of those people who reported their sickness were hospitalized while one died. The United States Food and Drug Administration determined that there was a connection between the nectarines, plums, and peaches from HMC Farms that were distributed and sold in retail stores around the country between May – Nov. 15 in 2022 and 2023. If you suffered listeria and other ill effects from fruit, you should call the seasoned Chicago-based Moll Law Group about what happened. Billions have been recovered in lawsuits with which we’ve been involved.

Consult the Seasoned Moll Law Group About Your Claim

HMC Farms, responding to the FDA announcement, issued a recall for certain conventionally grown fruit. Organic fruit was not recalled. And nectarines, plums and peaches sold at retail and grocery stores were not a part of the recall. The announcement from them noted that the fruit could be contaminated with Listeria monocytogenes, an organism that can trigger severe and even fatal infections, particularly in those who are pregnant or immune-compromised. When the affected person is pregnant, listeria can lead to losing the baby, giving birth prematurely, or giving the baby a life-threatening infection.

The announcement asked customers to take a look in their freezers to see if they had any of the fruit that was affected or had frozen it for later use.

Continue reading →

Published on: December 12, 2023

Supreme Court Heard Arguments to Challenge OxyContin Settlement

By Moll Law Group

headache-1540220_640-e1702313969782 The Supreme Court heard arguments related to a challenge to the bankruptcy deal that’s intended to compensate victims of highly addictive pain killer OxyContin. Based on the questions judges asked, court watchers believe the Court is split. The manufacturer of Oxycontin, Purdue Pharma, entered into a deal to pay billions to people harmed by the opioids they made and sold. That deal protected members of the Sackler family from personal liability. If you were injured by Oxycontin or another highly addictive pain killer, you should call the seasoned Chicago-based dangerous drug lawyers of Moll Law Group. Billions have been recovered in product liability lawsuits with which we’ve been involved.

Contact Moll Law Group About Your Claim

The case that the Court is hearing arose from complex circumstances. The Sackler family took assets from the manufacturer of Oxycontin, Purdue Pharm and shifted those assets overseas, which then triggered the problem that the company no longer has enough money to pay its creditors, such as those injured by pain killer. Purdue Pharma pled guilty to three criminal charges by 2020. It agreed that it owed $8 billion in criminal and civil fines to state and local governments trying to address the opioid crisis.

Based on this, the company reached a deal in bankruptcy court that would reimburse victims of the epidemic along with the harmed by an amount less than it might have paid, had it not shifted its assets overseas.

Continue reading →

Published on: November 28, 2023

Recall of WanaBana Apple Cinnamon Fruit Puree Pouches Due to Lead

By Moll Law Group

baby-2423896_640-e1699049689872 Recently, manufacturer WanaBana agreed with the FDA to voluntarily recall all WanaBana apple cinnamon fruit puree pouches because they have elevated lead levels. The warning asked parents and caregivers of children who consumed the pouches to contact their healthcare providers to get blood tests and advised parents not to buy WanaBana apple cinnamon fruit puree pouches. If your child may have been harmed by these pouches, call the seasoned Chicago-based product liability lawyers of Moll Law Group. Billions have been recovered in cases with which we’ve been involved. We represent injured consumers nationwide.

Call Moll Law Group About Your Claim

The FDA became aware of an issue with the apple cinnamon fruit pouches after four children were discovered to have elevated blood lead levels. The North Carolina Department of Health and Human Services examined multiple lot codes of the pouches and found very high lead concentrations. The FDA looked over the state department’s analytical findings and determined they could cause acute toxicity. The agency told the manufacturer that the pouches were a potential source of lead exposure. For its part, the manufacturer agreed to a voluntary recall once the FDA’s investigation found that all lot codes and expiration dates were affected. The pouches are sold across the country and are made available at retailers including Dollar Tree, Amazon, and Sam’s Club.

The company told the public that it is dedicated to making sure its products are safe. It also told consumers to stop using the product. It’s important to retain the pouch, if you can, when your child has symptoms of lead exposure, in case it’s needed for a product liability lawsuit.

Continue reading →

Published on: November 21, 2023

Joint Commission Releases Findings that 2023 Medical Errors May Exceed a Record High

By Moll Law Group

surgery-1822458_640-e1699051448285 The Joint Commission has released its data for the first half of 2023, and alarmingly, it shows that sentinel events are on track to surpass a record high found in 2022. Sentinel events are patient safety events that cause severe temporary harm, permanent harm, or death. If you or a loved one were injured through a doctor or staff error at a medical practice, please call the seasoned Chicago medical malpractice lawyers of Moll Law Group. We also handle claims regarding dangerous drugs and medical devices, making us ideally positioned to look at all angles by which liability may be proven.

Call Moll Law Group About Your Claim

Sentinel events are very serious. Among the common causes of sentinel events were teamwork failures, communication failures, failure to adhere to standard policies and procedures, wrong site surgery, wrong procedure, wrong patient, assault, rape, sexual assault, suicide, and treatment delays that cause further harm.

The injuries that result from these events can change the lives of you and your family forever. According to the Joint Commission data for the first half of 2023, of 720 reported and reviewed events during this time period, 18% caused patient death, 63% cause severe temporary harm, and 7% caused permanent harm. Tragically, many of the events were completely preventable.

Continue reading →

Published on: November 14, 2023

Eli Lilly Announces a Diabetes Drug Trial for Children

By Moll Law Group

woman-6532129_640-e1699049259188 Recently, Eli Lilly announced that it is planning a clinical trial of its diabetes drug Mounjaro in patients who are six years old or older that have obesity. In fact, according to a United States government registry, Eli Lilly is already underway with a Mounjaro trial on children as young as 10 years old who have type 2 diabetes. Meanwhile, the registry also indicates that the company Novo Nordisk, based in Germany, is also performing a late stage trial of the drug semaglutide, which is sold under the brand name Ozempic in kids who are only 6 years old. Ozempic has been reported to do harm, including gastroparesis. If you or your child is injured as a result of Mounjaro/Ozempic, please call the seasoned Chicago-based trial attorneys of Moll Law Group. We represent children nationwide.

Talk to Moll Law Group About Whether Your Claim is Viable

Both Mounjaro and Ozempic have surged in popularity and demand as treatments for diabetes and obesity. Ozempic is a brand name for semaglutide, which is a medication that manages patients’ blood sugar levels by copying the protein glucagon-like peptide 1 (GLP-1). It lowers your hunger cues and slows digestion in the gut, which can result in weight loss.

More than $1.5 billion in sales were generated by Eli Lilly in the first half of 2023, which is a year after it was approved in the United States. However, it is concerning that children will be subjected to clinical trials because there have been reports that these drugs cause harm, and lawsuits filed in connection with that harm. The Mounjaro lawsuits, which are in their infancy at the time, claim that the drug causes severe gastrointestinal trouble including intestinal blockage and gastroparesis and that Eli Lilly did not adequately inform of the risks associated with taking it.

Continue reading →

Published on: November 7, 2023

Bayer Returns a $332 Million Verdict in a Roundup Trial

By Moll Law Group

corn-83783_640 Recently, a jury found the company Bayer liable in a product liability lawsuit brought by plaintiff Mike Dennis who alleged his non-Hodgkin lymphoma was the result of exposure to Bayer’s Roundup weed killer. The jury ordered Bayer to pay $332 million in damages, of which $7 million is in compensatory damages and $325 million is in punitive damages. If you developed cancer and believe it was caused by exposure to Bayer’s Roundup, call the experienced Chicago-based lawyers of Moll Law Group. We represent clients nationwide.

Call Moll Law Group About Your Weed Killer Claim

The $332 million damages verdict was the third trial loss for Bayer this month. The prior verdicts in Roundup trials were $175 million and $1.25 million. However, these wins for the plaintiffs came after a string of nine consecutive trials with similar claims. In 2020, Bayer settled most of the Roundup claims against it for up to $10.9 billion. Around 40,000 Roundup-related cases are still in process against it.

With regard to this verdict, the jury agreed with Bayer in connection with two out of four legal claims. It found that the company failed to warn of Roundup’s risks, but that it was not negligent, and that the product was not defectively designed.

Continue reading →

Published on: October 24, 2023

Medline Industries Recalls Hudson RCI Addipak Unit Dose Vial, 0.9% Full Normal Saline Solution Due to Being Non-Sterile

By Moll Law Group

vial-5774206_1280-e1696439634427 Manufacturer Medline Industries initiated a recall of its Hudson RCI Addipak Unit Dose Vial, 0.9% full normal saline solution in July of this year. The FDA has categorized this recall as a Class I recall, which is the most severe kind of recall, reserved for cases in which use of a device could cause death or serious injuries. The recall affects lot 3B085 with distribution dates April 20, 2023 – July 14, 2023. 18,000 devices were recalled across the country. If you were harmed by units from the recalled lot, you should contact the seasoned Chicago-based attorneys of Moll Law Group. Billions have been recovered in cases with which we’ve been involved. We represent consumers across the country.

Call Moll Law Group About Your Claim

Medline Industries’ recall is based on the Lot 3B085 vials being non-sterile. While the affected lot passed the sterility testing, Lot 3B087, which was within the same cleaning cycle failed testing and exposed the impacted lot to possible contamination. When saline is non-sterile, there may be severe adverse health repercussions including infection, wheezing, nausea, discomfort, and difficulty breathing, along with potentially fatal sepsis and death. However, consumers have not reported injuries or deaths connected to the issue.

The recalled vials are used in connection with irrigation and inhalation therapy. Sometimes it is paired with a non-ventilator nebulizes to cleanse the lungs and irrigate the trachea. When irrigation therapy is used, the saline solution helps to clean wounds and flush the area. With inhalation therapy, the solution returns moisture to the lunches and reduces cold and allergy-created congestion.

Continue reading →

Published on: October 17, 2023

Kraft Recalls Processed American Cheese Slices Due to Possible Choking Risk

By Moll Law Group

PNG-image-300x200 Manufacturer Kraft Heinz discovered that one of the machines that individually wraps Kraft Singles American processed cheese slices permits thin strips of film to say on the slices even after removal of the wrapper. The food company announced a voluntary recall of more than 83,800 cases these slices. It’s believed the strips of film that stays on the cheeses present a potential choking danger or gagging hazard. The director of food safety and testing at Consumer Reports commented that any complicated machine requires adjustments to pieces of the equipment such that if adjustments aren’t right or in alignment with the specs, the machine may not do its job correctly, causing food safety problems. If you were harmed by Kraft processed American cheese slices, call the experienced Chicago-based product liability attorneys of Moll Law Group about the possibility of bringing a claim.

Contact Moll Law Group About Your Claim

Several customer complaints about finding plastic stuck to a slice, and 6 consumers’ complaints of choking and gagging as a result of this, led to the company investigating. No reports of injuries or serious health problems were made. The recall affects 16-ounce Kraft Singles American Pasteurized Prepared Cheese products. Their use-by date falls between Jan. 10, 2024, and Jan. 27, 2024. The recall also affects 3-pound multipacks of 72-count Kraft Singles American Pasteurized Prepared Cheese Product that have a best by date of January 9, 2024 – January 16, 2024.

The manufacturer has said that it repaired the wrapping machine and inspected the other machines that process the cheese. Consumer who bought recalled slices can return them to the store where they bought them for a refund or exchange.

Continue reading →

Published on: October 10, 2023

FDA Adds New Warnings to the Label of TEPEZZA

By Moll Law Group

eye-321961_1280-e1696438901920 The Food and Drug Administration recently updated the warning label on Horizon Pharmaceutical’s TEPEZZA. The label now includes that one of the “major recent changes” for warnings and precautions is “hearing impairment including hearing loss.” Hearing loss is just one of four warnings. The others are hyperglycemia, exacerbation of preexisting inflammatory bowel disease and infusion reactions. If you suffered hearing loss or other harm, you should call the trusted Chicago-based dangerous drug lawyers of Moll Law Group. Billions have been recovered in lawsuits around the country with which we’ve been involved.

Call Moll Law Group About a TEPEZZA Claim

Tepezza is a drug prescribed to improve symptoms of thyroid eye disease, which is a rare condition in which fatty tissue and muscles located behind the eye become inflamed such that the eye is pushed to the front and bulge outwards. The drug is supposed to mitigate the effects of double vision, proptosis, and chronic bulging eye. Unfortunately it is a drug that carries significant risks.

The new Tepezza warning provides that it can cause serious hearing impairment including hearing loss that could be permanent. Doctors are advised to evaluate a patient’s hearing before, during and after treatment with the drug and also weight the risks and benefits of treating a patient with the drug. The warning came a little less than a month after the Brazilian Health Regulatory Agency approved its use as a thyroid eye disease treatment.

Continue reading →